Search research articles
Contact Us
Filters
Showing results (251-260 of 300) with videos related to
Page
of 30
Sort By:
Nature Medicine
|
July 15, 2020
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, et al.
ACS Nano
|
June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju, Wen Shi Lee, Emily H Pilkington, et al.
The New England Journal of Medicine
|
June 23, 2021
SARS-CoV-2 Variants and Vaccines
Philip R Krause, Thomas R Fleming, Ira M Longini, et al.
The Journal of Infectious Diseases
|
February 25, 2016
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response
Anna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
The Journal of Infectious Diseases
|
March 25, 2015
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D Kirkpatrick, Anna P Durbin, Kristen K Pierce, et al.
JCI Insight
|
July 12, 2021
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
Ester Lopez, Ebene R Haycroft, Amy Adair, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 24, 2023
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
Amanda C Perofsky, John Huddleston, Chelsea Hansen, et al.
Nature Communications
|
February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Science Signaling
|
April 25, 2023
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release
Larisa I Labzin, Keng Yih Chew, Kathrin Eschke, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 300) with videos related to
Sort By:
Page
of 30
Nature Medicine
|
July 15, 2020
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A Juno, Hyon-Xhi Tan, Wen Shi Lee, et al.
ACS Nano
|
June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju, Wen Shi Lee, Emily H Pilkington, et al.
The New England Journal of Medicine
|
June 23, 2021
SARS-CoV-2 Variants and Vaccines
Philip R Krause, Thomas R Fleming, Ira M Longini, et al.
The Journal of Infectious Diseases
|
February 25, 2016
A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response
Anna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.
The Journal of Infectious Diseases
|
March 25, 2015
Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D Kirkpatrick, Anna P Durbin, Kristen K Pierce, et al.
JCI Insight
|
July 12, 2021
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
Ester Lopez, Ebene R Haycroft, Amy Adair, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 24, 2023
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
Amanda C Perofsky, John Huddleston, Chelsea Hansen, et al.
Nature Communications
|
February 20, 2021
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
Adam K Wheatley, Jennifer A Juno, Jing J Wang, et al.
Science Signaling
|
April 25, 2023
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release
Larisa I Labzin, Keng Yih Chew, Kathrin Eschke, et al.
Page
of 30